These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9719457)

  • 1. Rhodamine 123 efflux modulation in the presence of low or high serum from CD56+ hematopoietic cells or CD34+ leukemic blasts by B9309-068, a newly designed pyridine derivative.
    Beck JF; Buchholz F; Ulrich WR; Boer R; Sanders KH; Niethammer D; Gekeler V
    Cancer Lett; 1998 Jul; 129(2):157-63. PubMed ID: 9719457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhodamine 123-efflux from hematopoietic subpopulations and leukaemic blast populations marked by PerCP-conjugated monoclonal antibodies.
    Beck J; Gekeler V; Ringger M; Handgretinger R; Niethammer D
    Cancer Lett; 1996 Feb; 99(2):197-207. PubMed ID: 8616825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of multidrug resistance by BIBW22BS in blasts of de novo or relapsed or persistent acute myeloid leukemia ex vivo.
    Schröder J; Esteban M; Müller MR; Kasimir-Bauer S; Bamberger U; Heckel A; Seeber S; Scheulen ME
    J Cancer Res Clin Oncol; 1996; 122(5):307-12. PubMed ID: 8609155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro effect of GF120918, a novel reversal agent of multidrug resistance, on acute leukemia and multiple myeloma cells.
    den Ouden D; van den Heuvel M; Schoester M; van Rens G; Sonneveld P
    Leukemia; 1996 Dec; 10(12):1930-6. PubMed ID: 8946933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efflux of rhodamine from CD56+ cells as a surrogate marker for reversal of P-glycoprotein-mediated drug efflux by PSC 833.
    Robey R; Bakke S; Stein W; Meadows B; Litman T; Patil S; Smith T; Fojo T; Bates S
    Blood; 1999 Jan; 93(1):306-14. PubMed ID: 9864175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric functional analysis of multidrug resistance by Fluo-3: a comparison with rhodamine-123.
    Koizumi S; Konishi M; Ichihara T; Wada H; Matsukawa H; Goi K; Mizutani S
    Eur J Cancer; 1995 Sep; 31A(10):1682-8. PubMed ID: 7488425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assays for the analysis of P-glycoprotein in acute myeloid leukemia and CD34 subsets of AML blasts.
    Sonneveld P; Wiemer E
    Leukemia; 1997 Jul; 11(7):1160-5. PubMed ID: 9205006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR.
    de Bruin M; Miyake K; Litman T; Robey R; Bates SE
    Cancer Lett; 1999 Nov; 146(2):117-26. PubMed ID: 10656616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the multidrug inhibitor GG918 on drug sensitivity of human leukemic cells.
    Zhou DC; Simonin G; Faussat AM; Zittoun R; Marie JP
    Leukemia; 1997 Sep; 11(9):1516-22. PubMed ID: 9305607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a novel bisacridone and comparison with PSC 833 as a potent and poorly reversible modulator of P-glycoprotein.
    Horton JK; Thimmaiah KN; Altenberg GA; Castro AF; Germain GS; Gowda GK; Houghton PJ
    Mol Pharmacol; 1997 Dec; 52(6):948-57. PubMed ID: 9415704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased potency of MDR-modulators under serum conditions determined by a functional assay.
    Ludescher C; Eisterer W; Hilbe W; Hofmann J; Thaler J
    Br J Haematol; 1995 Nov; 91(3):652-7. PubMed ID: 8555069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effect of verapamil, cyclosporin A and SDZ PSC 833 on rhodamine 123 transport and cell cycle in vinblastine-resistant Chinese hamster ovary cells overexpressing P-glycoprotein.
    Pétriz J; Sánchez J; Bertrán J; García-López J
    Anticancer Drugs; 1997 Oct; 8(9):869-75. PubMed ID: 9402314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro efficacy of known P-glycoprotein modulators compared to droloxifene E and Z: studies on a human T-cell leukemia cell line and their resistant variants.
    Nüssler V; Pelka-Fleisc R; Gieseler F; Hasmann M; Löser R; Gullis E; Stötzer O; Zwierzina H; Wilmanns W
    Leuk Lymphoma; 1998 Nov; 31(5-6):589-97. PubMed ID: 9922050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute myeloid leukemia cells with low P-glycoprotein expression and high rhodamine 123 efflux capacity display high clonogenicity.
    Demur C; Muller C; Cassar G; Bousquet C; Laroche M; Laurent G
    Leukemia; 1998 Feb; 12(2):192-9. PubMed ID: 9519781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
    Guo A; Marinaro W; Hu P; Sinko PJ
    Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triggering noncycling hematopoietic progenitors and leukemic blasts to proliferate increases anthracycline retention and toxicity by downregulating multidrug resistance.
    Smeets ME; Raymakers RA; Vierwinden G; Pennings AH; Wessels H; de Witte T
    Blood; 1999 Oct; 94(7):2414-23. PubMed ID: 10498614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of multidrug resistance in de novo adult acute myeloid leukemia: variable efficacy of reverting agents in vitro. Eastern Cooperative Oncology Group.
    Paietta E; Andersen J; Racevskis J; Ashigbi M; Cassileth P; Wiernik PH
    Blood Rev; 1995 Mar; 9(1):47-52. PubMed ID: 7540903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells.
    Hitzl M; Drescher S; van der Kuip H; Schäffeler E; Fischer J; Schwab M; Eichelbaum M; Fromm MF
    Pharmacogenetics; 2001 Jun; 11(4):293-8. PubMed ID: 11434506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of phosphine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier.
    Luker GD; Rao VV; Crankshaw CL; Dahlheimer J; Piwnica-Worms D
    Biochemistry; 1997 Nov; 36(46):14218-27. PubMed ID: 9369495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug binding to P-glycoprotein is inhibited in normal tissues following SDZ-PSC 833 treatment.
    Jetté L; Murphy GF; Béliveau R
    Int J Cancer; 1998 May; 76(5):729-37. PubMed ID: 9610733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.